STOP GAMES Act of 2026 Stop The Overuse of Petitions and Get...
To amend subsection (q) of section 505 of the Federal Food, Drug, and Cosmetic Act to clarify the process for denying certain petitions whose primary purpose is to delay the approval of an application submitted under subsection (b)(2) or (j) of such section 505, and for other purposes.
The STOP GAMES Act of 2026 aims to streamline the process for drug approval by clarifying how to handle certain petitions that are primarily meant to delay approval. This bill targets petitions under the Federal Food, Drug, and Cosmetic Act, which aim to extend the time before a new drug can be approved and marketed. By addressing these petitions, the bill seeks to ensure that affordable medicines reach the market more quickly.
This bill would primarily affect pharmaceutical companies, healthcare providers, and patients who rely on timely access to new medications. By reducing unnecessary delays, the bill hopes to improve patient access to new and potentially life-saving treatments sooner.
HB8908 was introduced on May 19, 2026, and was immediately referred to the House Committee on Energy and Commerce. It is currently in its early stages, with initial discussions and reviews underway. Key next steps will involve committee analysis and potential amendments before it moves forward in the legislative process.
